These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 27207427)
1. A possible new role for Aβ in vascular and inflammatory dysfunction in Alzheimer's disease. Zamolodchikov D; Strickland S Thromb Res; 2016 May; 141 Suppl 2():S59-61. PubMed ID: 27207427 [TBL] [Abstract][Full Text] [Related]
2. The Alzheimer's disease peptide β-amyloid promotes thrombin generation through activation of coagulation factor XII. Zamolodchikov D; Renné T; Strickland S J Thromb Haemost; 2016 May; 14(5):995-1007. PubMed ID: 26613657 [TBL] [Abstract][Full Text] [Related]
3. Interactions of β-amyloid peptide with fibrinogen and coagulation factor XII may contribute to Alzheimer's disease. Ahn HJ; Chen ZL; Zamolodchikov D; Norris EH; Strickland S Curr Opin Hematol; 2017 Sep; 24(5):427-431. PubMed ID: 28661939 [TBL] [Abstract][Full Text] [Related]
4. A possible mechanism for the enhanced toxicity of beta-amyloid protofibrils in Alzheimer's disease. Chen ZL; Singh PK; Calvano M; Norris EH; Strickland S Proc Natl Acad Sci U S A; 2023 Sep; 120(36):e2309389120. PubMed ID: 37639602 [TBL] [Abstract][Full Text] [Related]
5. Neuroinflammation in Alzheimer's Disease: The Preventive and Therapeutic Potential of Polyphenolic Nutraceuticals. Sawikr Y; Yarla NS; Peluso I; Kamal MA; Aliev G; Bishayee A Adv Protein Chem Struct Biol; 2017; 108():33-57. PubMed ID: 28427563 [TBL] [Abstract][Full Text] [Related]
6. Fibrin deposited in the Alzheimer's disease brain promotes neuronal degeneration. Cortes-Canteli M; Mattei L; Richards AT; Norris EH; Strickland S Neurobiol Aging; 2015 Feb; 36(2):608-17. PubMed ID: 25475538 [TBL] [Abstract][Full Text] [Related]
7. Activation of the factor XII-driven contact system in Alzheimer's disease patient and mouse model plasma. Zamolodchikov D; Chen ZL; Conti BA; Renné T; Strickland S Proc Natl Acad Sci U S A; 2015 Mar; 112(13):4068-73. PubMed ID: 25775543 [TBL] [Abstract][Full Text] [Related]
8. Fibrinogen and altered hemostasis in Alzheimer's disease. Cortes-Canteli M; Zamolodchikov D; Ahn HJ; Strickland S; Norris EH J Alzheimers Dis; 2012; 32(3):599-608. PubMed ID: 22869464 [TBL] [Abstract][Full Text] [Related]
9. Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease. Cortes-Canteli M; Paul J; Norris EH; Bronstein R; Ahn HJ; Zamolodchikov D; Bhuvanendran S; Fenz KM; Strickland S Neuron; 2010 Jun; 66(5):695-709. PubMed ID: 20547128 [TBL] [Abstract][Full Text] [Related]
10. Focal inflammation in the brain: role in Alzheimer's disease. Cooper NR; Bradt BM; O'Barr S; Yu JX Immunol Res; 2000; 21(2-3):159-65. PubMed ID: 10852113 [TBL] [Abstract][Full Text] [Related]
11. Does a pro-inflammatory process precede Alzheimer's disease and mild cognitive impairment? Ferretti MT; Cuello AC Curr Alzheimer Res; 2011 Mar; 8(2):164-74. PubMed ID: 21345170 [TBL] [Abstract][Full Text] [Related]
12. β-Amyloid Orchestrates Factor XII and Platelet Activation Leading to Endothelial Dysfunction and Abnormal Fibrinolysis in Alzheimer Disease. García-Mejía KA; Custodio-Chablé SJ; Vázquez-Franco JE; Reyes-Maldonado E; Lezama RA Alzheimer Dis Assoc Disord; 2021 Jan-Mar 01; 35(1):91-97. PubMed ID: 33629978 [TBL] [Abstract][Full Text] [Related]
13. Activation of complement and contact system in Alzheimer's disease. Bergamaschini L; Donarini C; Gobbo G; Parnetti L; Gallai V Mech Ageing Dev; 2001 Nov; 122(16):1971-83. PubMed ID: 11589915 [TBL] [Abstract][Full Text] [Related]
14. Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors. Salminen A; Ojala J; Kauppinen A; Kaarniranta K; Suuronen T Prog Neurobiol; 2009 Feb; 87(3):181-94. PubMed ID: 19388207 [TBL] [Abstract][Full Text] [Related]
15. Prodromal Alzheimer's disease presenting as cerebral amyloid angiopathy-related inflammation with spontaneous amyloid-related imaging abnormalities and high cerebrospinal fluid anti-Aβ autoantibodies. Boncoraglio GB; Piazza F; Savoiardo M; Farina L; DiFrancesco JC; Prioni S; Tagliavini F; Parati EA; Giaccone G J Alzheimers Dis; 2015; 45(2):363-7. PubMed ID: 25537009 [TBL] [Abstract][Full Text] [Related]
16. Increased Number of Plasma B Cells Producing Autoantibodies Against Aβ42 Protofibrils in Alzheimer's Disease. Söllvander S; Ekholm-Pettersson F; Brundin RM; Westman G; Kilander L; Paulie S; Lannfelt L; Sehlin D J Alzheimers Dis; 2015; 48(1):63-72. PubMed ID: 26401929 [TBL] [Abstract][Full Text] [Related]
18. Innate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatment. Serpente M; Bonsi R; Scarpini E; Galimberti D Neuroimmunomodulation; 2014; 21(2-3):79-87. PubMed ID: 24557039 [TBL] [Abstract][Full Text] [Related]
19. Co-immunization with DNA and protein mixture: a safe and efficacious immunotherapeutic strategy for Alzheimer's disease in PDAPP mice. Liu S; Shi D; Wang HC; Yu YZ; Xu Q; Sun ZW Sci Rep; 2015 Jan; 5():7771. PubMed ID: 25586780 [TBL] [Abstract][Full Text] [Related]
20. When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer's disease. Avila-Muñoz E; Arias C Ageing Res Rev; 2014 Nov; 18():29-40. PubMed ID: 25078115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]